This is a guest post by Katie Coleman, a patient, advocate, and the founder of the Chromophobe and Oncocytic Tumor Alliance, a KCA Affiliate Partner. “ChRCC research, therefore, appears to be at an inflection point,…
What makes some cancers metastasize and spread or become resistant to treatment? Researchers at MD Anderson developed a model to predict when renal cell carcinoma (RCC), the most common type of kidney cancer, might become…
Claudia Tatum joined the KCA’s Patient & Caregiver Advisory Council in 2023. She is based in Oklahoma. What motivated you to get involved with the KCA’s PCAC? From the time I was diagnosed in Jan…
Annamaria Scaccia joined the KCA’s Patient & Caregiver Advisory Council (PCAC) in 2023. She is a frequent blog contributor for the KCA and collaborator on a number of special edition KCA newsletters. What motivated you…
Matt McClain joined the KCA’s Patient & Caregiver Advisory Council (PCAC) in 2023. What motivated you to get involved with the KCA’s PCAC? When I was newly diagnosed, I reached out to a few people…
This is a guest post by Michael Whitley, 46, who was diagnosed with stage 4 clear cell renal cell carcinoma in 2019. He is an engineer and lives in Huntsville, Alabama. Since my scan in…
By D’Ann George, PhD, Medical Writer This year’s American Society of Clinical Oncology meeting in June featured the first-ever symposium devoted to microbiome research in cancer. The “Role of the Microbiome in Immune CheckPoint Inhibitor…
Below are some highlights from research presented at the 2023 meeting of the American Society of Clinical Oncology, which took place in Chicago, Illinois from June 2-6. Cabozantinib plus nivolumab is a promising treatment for…
Dr. Julia Stevens, PharmD, BCOP, is a Clinical Pharmacy Specialist in Ambulatory Oncology at Beth Israel Deaconess Medical Center in Boston, Massachusetts. She specializes in kidney cancer, prostate cancer, and melanoma. Her primary clinical responsibilities…
Dr. Emily Wang, PharmD, BCOP, is a Clinical Pharmacy Specialist – Genitourinary Medical Oncology at MD Anderson Cancer Center in Houston, Texas. What motivated you to get involved with the KCA? I had heard about…